• Title/Summary/Keyword: Synthetic biology

Search Result 356, Processing Time 0.032 seconds

Novel High-Throughput DNA Part Characterization Technique for Synthetic Biology

  • Bak, Seong-Kun;Seong, Wonjae;Rha, Eugene;Lee, Hyewon;Kim, Seong Keun;Kwon, Kil Koang;Kim, Haseong;Lee, Seung-Goo
    • Journal of Microbiology and Biotechnology
    • /
    • v.32 no.8
    • /
    • pp.1026-1033
    • /
    • 2022
  • This study presents a novel DNA part characterization technique that increases throughput by combinatorial DNA part assembly, solid plate-based quantitative fluorescence assay for phenotyping, and barcode tagging-based long-read sequencing for genotyping. We confirmed that the fluorescence intensities of colonies on plates were comparable to fluorescence at the single-cell level from a high-end, flow-cytometry device and developed a high-throughput image analysis pipeline. The barcode tagging-based long-read sequencing technique enabled rapid identification of all DNA parts and their combinations with a single sequencing experiment. Using our techniques, forty-four DNA parts (21 promoters and 23 RBSs) were successfully characterized in 72 h without any automated equipment. We anticipate that this high-throughput and easy-to-use part characterization technique will contribute to increasing part diversity and be useful for building genetic circuits and metabolic pathways in synthetic biology.

Sustainable production of natural products using synthetic biology: Ginsenosides

  • So-Hee Son;Jin Kang;YuJin Shin;ChaeYoung Lee;Bong Hyun Sung;Ju Young Lee;Wonsik Lee
    • Journal of Ginseng Research
    • /
    • v.48 no.2
    • /
    • pp.140-148
    • /
    • 2024
  • Synthetic biology approaches offer potential for large-scale and sustainable production of natural products with bioactive potency, including ginsenosides, providing a means to produce novel compounds with enhanced therapeutic properties. Ginseng, known for its non-toxic and potent qualities in traditional medicine, has been used for various medical needs. Ginseng has shown promise for its antioxidant and neuroprotective properties, and it has been used as a potential agent to boost immunity against various infections when used together with other drugs and vaccines. Given the increasing demand for ginsenosides and the challenges associated with traditional extraction methods, synthetic biology holds promise in the development of therapeutics. In this review, we discuss recent developments in microorganism producer engineering and ginsenoside production in microorganisms using synthetic biology approaches.

A Genetically Encoded Biosensor for the Detection of Levulinic Acid

  • Tae Hyun Kim;Seung-Gyun Woo;Seong Keun Kim;Byeong Hyeon Yoo;Jonghyeok Shin;Eugene Rha;Soo Jung Kim;Kil Koang Kwon;Hyewon Lee;Haseong Kim;Hee-Taek Kim;Bong-Hyun Sung;Seung-Goo Lee;Dae-Hee Lee
    • Journal of Microbiology and Biotechnology
    • /
    • v.33 no.4
    • /
    • pp.552-558
    • /
    • 2023
  • Levulinic acid (LA) is a valuable chemical used in fuel additives, fragrances, and polymers. In this study, we proposed possible biosynthetic pathways for LA production from lignin and poly(ethylene terephthalate). We also created a genetically encoded biosensor responsive to LA, which can be used for screening and evolving the LA biosynthesis pathway genes, by employing an LvaR transcriptional regulator of Pseudomonas putida KT2440 to express a fluorescent reporter gene. The LvaR regulator senses LA as a cognate ligand. The LA biosensor was first examined in an Escherichia coli strain and was found to be non-functional. When the host of the LA biosensor was switched from E. coli to P. putida KT2440, the LA biosensor showed a linear correlation between fluorescence intensity and LA concentration in the range of 0.156-10 mM LA. In addition, we determined that 0.156 mM LA was the limit of LA detection in P. putida KT2440 harboring an LA-responsive biosensor. The maximal fluorescence increase was 12.3-fold in the presence of 10 mM LA compared to that in the absence of LA. The individual cell responses to LA concentrations reflected the population-averaged responses, which enabled high-throughput screening of enzymes and metabolic pathways involved in LA biosynthesis and sustainable production of LA in engineered microbes.

Artificial, All Too Natural: Synthetic Biology and Transhumanism in the Post-Genomic Era (인공적인, 너무나 자연적인: 포스트 게놈 시대 합성생물학과 트랜스휴머니즘)

  • Woo, Taemin;Park, Buhm Soon
    • Journal of Science and Technology Studies
    • /
    • v.16 no.2
    • /
    • pp.33-63
    • /
    • 2016
  • This paper compares and contrasts the concept of nature and the theory of evolution held by leading synthetic biologists and transhumanists in the post-genomic era. Synthetic biology, which emerged in the early 2000s, aims to design biological systems that perform specific functions with the two key concepts of "rational design" and "directed evolution". However, synthetic biology has also raised serious concerns about the creation of man-made biological materials and the manipulation of the direction and speed of evolution. It is no wonder that transhumanists, who dream of creating new, enhanced human species, have welcomed the arrival of synthetic biology. How, then, can we deal with the nature reinvented by synthetic biology? By what means can one justify research that may affect the process of evolution? What intellectual resources do synthetic biology and transhumanism share in common? What influence would the new trend of commercialization of science and technology exert upon the development of synthetic biology? Addressing those questions, this paper argues that the moral authority of nature can be restored in this post-genomic era.

Fructan Biosynthesis by Yeast Cell Factories

  • Hyunjun Ko;Bong Hyun Sung;Mi-Jin Kim;Jung-Hoon Sohn;Jung-Hoon Bae
    • Journal of Microbiology and Biotechnology
    • /
    • v.32 no.11
    • /
    • pp.1373-1381
    • /
    • 2022
  • Fructan is a polysaccharide composed of fructose and can be classified into several types, such as inulin, levan, and fructo-oligosaccharides, based on their linkage patterns and degree of polymerization. Owing to its structural and functional diversity, fructan has been used in various fields including prebiotics, foods and beverages, cosmetics, and pharmaceutical applications. With increasing interest in fructans, efficient and straightforward production methods have been explored. Since the 1990s, yeast cells have been employed as producers of recombinant enzymes for enzymatic conversion of fructans including fructosyltransferases derived from various microbes and plants. More recently, yeast cell factories are highlighted as efficient workhorses for fructan production by direct fermentation. In this review, recent advances and strategies for fructan biosynthesis by yeast cell factories are discussed.

Synthetic Bacteria for Therapeutics

  • Lam VO, Phuong N.;Lee, Hyang-Mi;Na, Dokyun
    • Journal of Microbiology and Biotechnology
    • /
    • v.29 no.6
    • /
    • pp.845-855
    • /
    • 2019
  • Synthetic biology builds programmed biological systems for a wide range of purposes such as improving human health, remedying the environment, and boosting the production of valuable chemical substances. In recent years, the rapid development of synthetic biology has enabled synthetic bacterium-based diagnoses and therapeutics superior to traditional methodologies by engaging bacterial sensing of and response to environmental signals inherent in these complex biological systems. Biosynthetic systems have opened a new avenue of disease diagnosis and treatment. In this review, we introduce designed synthetic bacterial systems acting as living therapeutics in the diagnosis and treatment of several diseases. We also discuss the safety and robustness of genetically modified synthetic bacteria inside the human body.

Current Challenges in Bacterial Transcriptomics

  • Cho, Suhyung;Cho, Yoobok;Lee, Sooin;Kim, Jayoung;Yum, Hyeji;Kim, Sun Chang;Cho, Byung-Kwan
    • Genomics & Informatics
    • /
    • v.11 no.2
    • /
    • pp.76-82
    • /
    • 2013
  • Over the past decade or so, dramatic developments in our ability to experimentally determine the content and function of genomes have taken place. In particular, next-generation sequencing technologies are now inspiring a new understanding of bacterial transcriptomes on a global scale. In bacterial cells, whole-transcriptome studies have not received attention, owing to the general view that bacterial genomes are simple. However, several recent RNA sequencing results are revealing unexpected levels of complexity in bacterial transcriptomes, indicating that the transcribed regions of genomes are much larger and complex than previously anticipated. In particular, these data show a wide array of small RNAs, antisense RNAs, and alternative transcripts. Here, we review how current transcriptomics are now revolutionizing our understanding of the complexity and regulation of bacterial transcriptomes.

Synthetic Biology Tools for Novel Secondary Metabolite Discovery in Streptomyces

  • Lee, Namil;Hwang, Soonkyu;Lee, Yongjae;Cho, Suhyung;Palsson, Bernhard;Cho, Byung-Kwan
    • Journal of Microbiology and Biotechnology
    • /
    • v.29 no.5
    • /
    • pp.667-686
    • /
    • 2019
  • Streptomyces are attractive microbial cell factories that have industrial capability to produce a wide array of bioactive secondary metabolites. However, the genetic potential of the Streptomyces species has not been fully utilized because most of their secondary metabolite biosynthetic gene clusters (SM-BGCs) are silent under laboratory culture conditions. In an effort to activate SM-BGCs encoded in Streptomyces genomes, synthetic biology has emerged as a robust strategy to understand, design, and engineer the biosynthetic capability of Streptomyces secondary metabolites. In this regard, diverse synthetic biology tools have been developed for Streptomyces species with technical advances in DNA synthesis, sequencing, and editing. Here, we review recent progress in the development of synthetic biology tools for the production of novel secondary metabolites in Streptomyces, including genomic elements and genome engineering tools for Streptomyces, the heterologous gene expression strategy of designed biosynthetic gene clusters in the Streptomyces chassis strain, and future directions to expand diversity of novel secondary metabolites.

Characterization of Acyl-CoA Oxidases from the Lipolytic Yeast Candida aaseri SH14

  • Ibrahim, Zool Hilmi;Bae, Jung-Hoon;Sung, Bong Hyun;Kim, Mi-Jin;Rashid, Ahmad Hazri Ab;Sohn, Jung-Hoon
    • Journal of Microbiology and Biotechnology
    • /
    • v.32 no.7
    • /
    • pp.949-954
    • /
    • 2022
  • The lipolytic yeast Candida aaseri SH14 contains three Acyl-CoA oxidases (ACOXs) which are encoded by the CaAOX2, CaAOX4, and CaAOX5 genes and catalyze the first reaction in the β-oxidation of fatty acids. Here, the respective functions of the three CaAOX isozymes were studied by growth analysis of mutant strains constructed by a combination of three CaAOX mutations in minimal medium containing fatty acid as the sole carbon source. Substrate specificity of the CaAOX isozymes was analyzed using recombinant C. aaseri SH14 strains overexpressing the respective genes. CaAOX2 isozyme showed substrate specificity toward short- and medium-chain fatty acids (C6-C12), while CaAOX5 isozyme preferred long-chain fatty acid longer than C12. CaAOX4 isozyme revealed a preference for a broad substrate spectrum from C6-C16. Although the substrate specificity of CaAOX2 and CaAOX5 covers medium- and long-chain fatty acids, these two isozymes were insufficient for complete β-oxidation of long-chain fatty acids, and therefore CaAOX4 was indispensable.